147 related articles for article (PubMed ID: 7961203)
1. Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Perea EJ; Garcia Iglesias MC
J Antimicrob Chemother; 1994 Jul; 34(1):161-4. PubMed ID: 7961203
[No Abstract] [Full Text] [Related]
2. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
Doern GV
Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
[TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
Barry AL; Fuchs PC; Pfaller MA
Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Dec; 38(12):2902-4. PubMed ID: 7695280
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
Doern GV; Tubert TA
Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Liljequist BO; Gezelius L
Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Delmée M; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889
[TBL] [Abstract][Full Text] [Related]
9. [In vitro effect of cefixime against Haemophilus influenzae].
Dabernat H; Delmas C
Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
Nash DR; Flanagan C; Steele LC; Wallace RJ
Antimicrob Agents Chemother; 1991 Jan; 35(1):192-4. PubMed ID: 1901696
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A
Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
[TBL] [Abstract][Full Text] [Related]
13. Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Bingen E; Bourgeois F; Chardon H; Doit C; Lambert-Zechovsky N
Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):923-6. PubMed ID: 1486888
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.
Mortensen JE; Himes SL
Antimicrob Agents Chemother; 1990 Jul; 34(7):1456-8. PubMed ID: 2386375
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
Williams JD; Powell M; Fah YS; Seymour A; Yuan M
Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Tremblay LD; L'Ecuyer J; Provencher P; Bergeron MG
CMAJ; 1990 Nov; 143(9):895-901. PubMed ID: 2224717
[TBL] [Abstract][Full Text] [Related]
17. [Study of susceptibility of Haemophilus influenzae to beta-lactams by using HTM gelose (Haemophilus test medium)].
Dabernat H; Seguy M; Delmas C
Pathol Biol (Paris); 1993 Sep; 41(7):589-95. PubMed ID: 8255610
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of 206 Haemophilus influenzae isolates collected from children in central Italy.
Zanchi A; Mencarelli M; Sansoni A; Rossolini A; Cellesi C
Eur J Epidemiol; 1994 Dec; 10(6):699-702. PubMed ID: 7672050
[TBL] [Abstract][Full Text] [Related]
19. [Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Cisterna R; Fresnadillo MJ; García-Rodríguez JA; Gobernado M; Martín R; Perea E; Picazo J
Rev Esp Quimioter; 1998 Sep; 11(3):245-50. PubMed ID: 9795311
[TBL] [Abstract][Full Text] [Related]
20. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.
Fuchs PC; Barry AL
J Clin Microbiol; 1994 Nov; 32(11):2846-50. PubMed ID: 7852584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
